4/30/2012

Vivus' avanafil, a PDE-5 inhibitor, received FDA approval for erectile dysfunction. Dr. Victoria Kusiak of the FDA Center for Drug Evaluation and Research said the "approval expands the available treatment options to men experiencing erectile dysfunction and enables patients ... to choose the most appropriate treatment for their needs."

Related Summaries